US 6,653,306 B1Granted

Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy

AssigneeG.D. Searle & Co.

InventorsJohn C. Alexander, Joseph R. Schuh, Richard J. Gorczynski

Life of this patent

Estimating the term…

Abstract

A combination comprising therapeutically-effective amount of an epoxy-steroidal aldosterone receptor antagonist and a therapeutically-effective amount of an angiotensin II receptor antagonist is described for treatment of circulatory disorders.

Claims34

Dependent claims

A combination comprising a therapeutically-effective amount of an angiotensin II receptor antagonist and a therapeutically-effective amount of an epoxy-steroidal aldosterone receptor antagonist.

Dependencies are inferred from the claim text.

Facts

Application: 08/781,786Filed 9 Jan 1997 · continuation
Priority: 7 Jun 1995
Granted: 25 Nov 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 31/585
Containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin: containing lactone rings, e.g. oxandrolone, bufalin
A61P 9/00
Drugs for disorders of the cardiovascular system
A61P 9/04
Drugs for disorders of the cardiovascular system: inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Family

Application08/486,456Parent of this continuation · filed 7 Jun 1995
US 6,653,306 B1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results